Poster Session

[P44] Poster Session 44　Lung Cancer/Thoracic Cancer（Genome biomarker）

+Add all to schedule

[P44-1] Discrepancy in MET exon 14 skipping mutation measurement between ArcherMET and Oncomine Dx Target Test system

^○Kanako Shinada¹, Shuji Murakami¹, Seigo Katakura¹, Ushio Ryota¹, Tetsuro Kondo¹, Terufumi Kato¹, Tomoyuki Yokose², Haruhiro Saito¹ (1.Department of Thoracic Oncology, Kanagawa Cancer Center, 2.Department of Pathology, Kanagawa Cancer Center)

[P44-2] Comparison of modalities for evaluation of MET exon 14 skipping mutation in non-small-cell lung cancer

^○Yuki Shinno¹, Yuki Takeyasu¹, Tatsuya Yoshida^1,2, Ken Masuda¹, Yuji Matsumoto¹, Yusuke Okuma¹, Yasushi Goto¹, Hidehito Horinouchi¹, Noboru Yamamoto^1,2, Yasushi Yatabe³, Yuichiro Ohe¹ (1.Department of Thoracic Oncology, National Cancer Center Hospital, 2.Department of Experimental Therapeutics, National Cancer Center Hospital, 3.Department of Diagnostic Pathology, National Cancer Center Hospital)

[P44-3] Reflections on the tests and treatments performed for incurable advanced non-small cell lung cancer at our hospital

^○Kiyohide Komuta, Riiko Kitou, Satoshi Tanizaki, Tomohiro Kanai, Satoshi Tanaka, Junji Uchida, Kiyonobu Ueno (Department of Respiratory Medicine, Osaka General Medical Center)

[P44-4] Analysis of Oncomine Dx Target Test at our hospital and its usefulness in clinical practice

^○Shinji Chiba¹, Shinnosuke Oura¹, Katsuya Chou¹, Tatsuya Hashimoto¹, Hirotaka Saikawa¹, Takashi Ito¹, Ami Matsumoto¹, Itaru Fujimura¹, Masachika Akiyama¹, Yu Utsumi¹, Hiromi Nagashima¹, Naoki Yanagwa², Tamotsu Sugai², Makoto Maemondo¹ (1.Division of Pulmonary Medicine, Department of Internal Medicine, Iwate Medical University, 2.Department of Molecular Diagnostic Pathology, Iwate Medical University School of Medicine)

[P44-5] Daily use of NGS for lung cancer in our hospital

^○Takeshi Kaihara, Ryuji Hayashi, Shinya Kajiura, Toshiro Miwa (Clinical Oncology, Toyama University Hospital)